New Data Inspire Global Experts to Call for Improved Education, Awareness and Support for Head and Neck Cancer Patients
SummaryMerck Serono, a division of Merck KGaA, Darmstadt Germany, in partnership with the European Head and Neck Society (EHNS), will convene an expert panel of physicians, who will issue a call-to-action that will focus on providing tailored information, advice and better support networks to head and neck cancer patients.
- New pan-European survey provides insights into the priorities and unmet needs of head and neck cancer patients
- The EHNS, supported by Merck Serono, now plans to develop and implement an action plan aimed at improving head and neck cancer education, awareness and support
This call-to-action is driven by the results of ‘About Face 2’, a new survey of European head and neck cancer patients, presented at the European Multidisciplinary Cancer Congress 2011. The survey uncovered unmet needs at key junctures of the patient journey from pre-diagnosis, at diagnosis, at treatment and post-treatment. Surveyed head and neck cancer patients identified the following areas of unmet need:1
- Improved education on head and neck cancer to facilitate earlier diagnosis
- Easy-to-understand information about the disease and treatment options
- Help in cultivating a positive attitude to combat the disease
- Guidance to consider the best available treatment choice for each patient’s situation
- Improved support and counseling from an extended network of resources to help patients cope with the disease burden
This expert panel will take place as part of the ‘Senseless’ Satellite Symposium, which includes a unique theatrical performance portraying a head and neck cancer patient’s journey, including communication barriers and emotional aspects of the disease.
“Merck Serono is committed to helping improve the lives of head and neck cancer patients,” said Dr. Wolfgang Wein, Executive Vice President, Oncology, Merck KGaA. “By partnering with the EHNS and leading experts, Merck Serono is taking innovative steps to help ensure that early diagnosis, optimal communication and educational support are integral parts of the standard of care in head and neck cancer.”
The ‘Senseless’ Satellite Symposium will take place at the Stockholmsmässan Congress Center in Hall A3 between 18:30 and 20:00 on September 26, 2011. All delegates registered for the European Multidisciplinary Cancer Congress are warmly welcomed to attend.
Please visit www.globalcancernews.com for further news about the ‘Senseless’ Satellite Symposium at the European Multidisciplinary Cancer Congress 2011.
To learn more about the call-to-action, please visit the EHNS website www.ehns.org.